Recombinant Mouse C-X-C motif chemokine 9 protein (Cxcl9), partial (Active)

In Stock
Code CSB-AP001131MO
Abbreviation Recombinant Mouse Cxcl9 protein, partial (Active)
MSDS
Size $142
Order now
Image
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Purity
>95% as determined by SDS-PAGE.
Endotoxin
Less than 1.0 EU/μg as determined by LAL method.
Activity
Fully biologically active when compared to standard. The biological activity determined by a chemotaxis bioassay using human lymphocytes is in a concentration range of 0.1-1.0 ng/ml.
Target Names
Uniprot No.
Research Area
Immunology
Alternative Names
Cxcl9; Mig; Scyb9C-X-C motif chemokine 9; Gamma-interferon-induced monokine; Monokine induced by interferon-gamma; MIG; MuMIG; Protein m119; Small-inducible cytokine B9
Species
Mus musculus (Mouse)
Source
E.coli
Expression Region
22-126
Complete Sequence
TLVIRNARCS CISTSRGTIH YKSLKDLKQF APSPNCNKTE IIATLKNGDQ TCLDPDSANV KKLMKEWEKK INQKKKQKRG KKHQKNMKNR KPKTPQSRRR SRKTT
Mol. Weight
12.2 kDa
Protein Length
Partial of M34815
Tag Info
Tag-Free
Form
Lyophilized powder
Buffer
Lyophilized from a 0.2 µm filtered PBS, pH 7.4
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Troubleshooting and FAQs
Storage Condition
Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Shelf Life
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Lead Time
5-10 business days
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet & COA
Please contact us to get it.
Description

Recombinant Mouse C-X-C motif chemokine 9 protein (Cxcl9) is produced in E. coli and covers amino acid sequence 22-126 of the protein. This tag-free product achieves purity greater than 95% as determined by SDS-PAGE, with endotoxin levels below 1.0 EU/µg, verified by the LAL method. The protein appears to be fully biologically active, demonstrated by its ability to induce chemotaxis of human lymphocytes at concentrations ranging from 0.1 to 1.0 ng/ml.

Also known as MIG (monokine induced by gamma interferon), Cxcl9 is a chemokine that participates in immunological responses, particularly lymphocyte recruitment. The protein plays a significant role in inflammation and immune surveillance by guiding immune cells to sites of infection or injury. Because of its important role in immune signaling pathways, Cxcl9 represents a crucial protein for research into immune responses and inflammatory processes.

Potential Applications

Note: The applications listed below are based on what we know about this protein's biological functions, published research, and experience from experts in the field. However, we haven't fully tested all of these applications ourselves yet. We'd recommend running some preliminary tests first to make sure they work for your specific research goals.

1. Lymphocyte Chemotaxis Assays

This recombinant mouse Cxcl9 protein can serve as a positive control or standard in chemotaxis bioassays when studying lymphocyte migration patterns. Given its demonstrated biological activity in human lymphocyte chemotaxis assays at concentrations of 0.1-1.0 ng/ml, researchers may be able to establish dose-response curves and validate experimental conditions. The protein's high purity (>95%) and low endotoxin levels make it suitable for cell-based assays where contamination could interfere with migration responses. This application appears particularly valuable for investigating immune cell trafficking mechanisms in preclinical research models.

2. Comparative Species Cross-Reactivity Studies

The demonstrated cross-species activity of this mouse Cxcl9 protein on human lymphocytes creates an opportunity to investigate chemokine receptor binding specificity and evolutionary conservation. Researchers can compare chemotactic responses of lymphocytes from different species to determine the extent of functional conservation across mammalian Cxcl9 orthologs. This application supports fundamental research into chemokine-receptor interactions and can inform the design of translational studies between mouse models and human systems.

3. Antibody Development and Validation

This biologically active recombinant protein serves as an ideal antigen for generating mouse Cxcl9-specific antibodies or validating existing antibody preparations. The tag-free nature ensures that antibodies will recognize the native protein sequence without interference from artificial epitopes. Researchers can use this protein in ELISA development, Western blot validation, and immunoassay standardization. The confirmed biological activity provides an additional functional readout to complement immunological detection methods.

4. Protein-Protein Interaction Studies

The recombinant Cxcl9 protein can be applied in biochemical assays to identify and characterize binding partners, particularly chemokine receptors such as CXCR3. Surface plasmon resonance, bio-layer interferometry, or pull-down assays may use this protein to determine binding kinetics and affinities. High purity and biological activity should ensure reliable results in binding studies, while the low endotoxin content prevents interference in sensitive biochemical assays.

5. Structure-Function Relationship Analysis

This biologically active protein provides a reference standard for mutagenesis studies aimed at understanding critical residues for Cxcl9 function. Researchers can compare the chemotactic activity of protein variants against this wild-type recombinant protein using the established lymphocyte migration assay. The defined expression region (22-126) and confirmed activity enable systematic investigation of how specific amino acid modifications affect biological function, supporting protein engineering and mechanistic studies.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
May be a cytokine that affects the growth, movement, or activation state of cells that participate in immune and inflammatory response.
Gene References into Functions
  1. although the expression of CXCL9 and CXCL11 are increased after spinal nerve ligation, they may not contribute to the maintenance of neuropathic pain. PMID: 29712506
  2. Cxcl9 has a role in angiogenesis and osteogenesis in bone. PMID: 27966526
  3. Data suggest that the CXCL9-CXCR3 axis plays a pivotal role in the liver-specific distribution of TRAIL+ NK cells in mice. PMID: 29088306
  4. IFNalphaR1 signaling promoted CXCL9 and CXCL10 synthesis, suggesting that these chemokines might be involved in the LPS and CD134 costimulation response. PMID: 28432083
  5. CXCL10 plays in the pathogenesis of recurrent Herpetic stromal keratitis, and that CXCL9 displays its importance when CXCL10 is absent. PMID: 28282568
  6. CXCL9 expression is strongly upregulated in PGRN KO mice and its level is correlated with severity of inflammation in a dermatitis model. PMID: 26892362
  7. hepatic expression of the inflammatory CXC chemokine ligands (CXCL)9 and CXCL10 strongly increased whereas homeostatic CXCL12 significantly decreased. PMID: 26052942
  8. Here, we report the evidence for the production of MIG, a second CXCR3 ligand, during the primary immune response to HSV-1 corneal infection. PMID: 25207638
  9. These findings identify a novel role for the immune cell-derived CXCL9 chemokine in directing a protective antimicrobial response in the intestinal mucosa. PMID: 25643352
  10. These results indicate that CXCL9 is crucial for recruiting immune T cells into the brain and inducing an accumulation of the T cells into the areas where tachyzoites proliferate to prevent reactivation of chronic T. gondii infection. PMID: 25432064
  11. tumours are characterized by expression of inflammatory chemokines (CCL2, CCL5, CCL7, CCL8, CCL12, CXCL9, CXCL10 and CX3CL1), reflected by an enrichment of activated Foxp3(-) and Foxp3(+) T cells PMID: 25495686
  12. Aged mice had similar levels of IL-1beta, TNF, IFN-gamma, IL-17, and granulocyte colony-stimulating factor following S. pneumoniae infection, compared with young mice, but increased levels of the chemokines CXCL9, CXCL12, CCL3, CCL4, CCL5, CCL11, and CCL17. PMID: 25595646
  13. Data indicate that a feed-forward CXCL9-dependent circuit provided additional chemotactic cues that further increase local memory cell density. PMID: 23352234
  14. IFN-gamma-mediated loss of Mig expression in cutaneous tumors as a potent mechanism of immunoediting that results in increased tumor resistance to T cell-mediated immunity. PMID: 23241877
  15. CXCL9/10 have antifibrotic roles on liver non-parenchymal cells PMID: 22905138
  16. findings show that effector T cells cannot accumulate within the decidua, the specialized stromal tissue encapsulating the fetus and placenta; impaired accumulation was in part attributable to the epigenetic silencing of key T cell-attracting inflammatory chemokine genes in decidual stromal cells PMID: 22679098
  17. Mig contributes to the acute lethal toxicity arising from 5-FU administration. PMID: 22474250
  18. Cxcr3, Cxcl9 and Cxcl10 are increased in alopecia areata. PMID: 22358057
  19. The results identify direct angiostatic and antifibrotic effects of the Cxcr3 ligand Cxcl9 in a model of experimental liver fibrosis. PMID: 22237831
  20. MIG/CXCL9 is expressed in the lungs upon pneumococcal infection in a MyD88-dependent manner PMID: 20381636
  21. Expression of the chemokine Mig (CXCL9) was increased 2.8-fold in tumors from Egr-1 knockout mice. PMID: 19200397
  22. CXCL9 promotes the development of IFN-gamma-producing CD8 T cells, and CXCL10 antagonizes this skewing during allograft rejection. PMID: 20194716
  23. CCL2, CXCL9 and CXCL2 mRNA are up-regulated after oral Salmonella infection in Peyer's patches and lymph nodes coincident with the first arrival of monocytes and neutrophils PMID: 19839009
  24. MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma. PMID: 11731434
  25. in study of relevance of chemokine expression to selective migration of t-cells and the disease localization in murine graft-versus-host disease, Mig was found to be predominantly expressed in spleen, liver, and not skin, and not heart. PMID: 12098066
  26. NF-kappaB has a critical role in mediating IFN-gamma-induced MIG (monokine induced by IFN-gamma) expression independent of hyaluronan PMID: 12226082
  27. involved in T cell cardiac allograft vasculopathy PMID: 12368204
  28. Data show that the transcriptional coactivator CREB-binding protein (CBP) mediated the STAT1/NF-kappaB synergy for transcription of the gene for CXC ligand 9 an interferon-gamma (IFN-gamma)-inducible chemokine. PMID: 12403783
  29. full potency of SLC/CCL21-mediated anti-tumor responses require in part the induction of IFNgamma, MIG/CXCL9 and IP-10/CXCL10 PMID: 12740040
  30. Peak of expression of CXCL9 and CXCL10 occurred 4 days before CD8+ T cells infiltrated infected tissues. CXCL9 and CXCL10 may play role early during immune response against rickettsial infections. PMID: 14507644
  31. Mig functions as a negative regulator of murine eosinophils PMID: 14769916
  32. exogenous CXCL9 stimulated CD4 lymphocyte proliferation in a MHC class II-mismatched MLR and increased the number of IFN-gamma-producing CD4 lymphocytes PMID: 15187119
  33. Interactions involving CXCR3 and its primary ligands Mig and IP-10 significantly contribute to donor T cell recruitment to the lung after allogeneic stem cell transplantation. PMID: 15265940
  34. RANKL stimulates the serine phosphorylation of STAT1, causing MIG gene transcription and secretion, which may have a role in recruiting CXCR3-positive osteoclast precursors and osteoclasts to bone remodeling or inflammatory sites. PMID: 15585657
  35. IFN-gamma knockout mice, which manifested depressed ear-swelling following delayed hypersensitsivity challenge, made no Mig. PMID: 15629884
  36. Results suggest that in the sensitized host, CXCR3, IP-10, and Mig are required for optimal delayed hypersensitivity responsiveness but are not essential for containing HSV-1 replication. PMID: 15708587
  37. results suggest that MUM1 plays roles in the progression of B-cell lymphoma/leukemia by regulating the expression of various genes including MIG. PMID: 15959530
  38. CXCL9 has a role in graft rejection in the absence of CCL19 and CCL21 PMID: 16095489
  39. MIG mRNA expression in the lungs of Klebsiella-infected mice requires the endogenous production of IFN-gamma. PMID: 16299319
  40. CXCL9 signaling enhances immune responses following Trypanosoma cruzi infection; transcripts for CXCL9 remain elevated during chronic infection PMID: 16368965
  41. CXCL9 is up-regulated in unique patterns following tracheal transplantation in mice. Deletion of CXCL9 does not affect airway obliteration. PMID: 16709871
  42. These results suggest that the more aggressive rejection of xenografts compared with allografts is due to the earlier expression of CXC-chemokines, IP-10 and MIG, and subsequent adjuvant effects of proinflammatory cytokines. PMID: 16768726
  43. Collectively, the results suggest a non-redundant role for CXCL9 and CXCL10 in response to ocular HSV-1 infection in terms of controlling virus replication and recruitment of CD4(+) T cells into the cornea. PMID: 17296171
  44. Acute ethanol intoxication impairs lung expression of Cxcl9, interfering with pulmonary response to bacterial challenge. PMID: 17889309
  45. IFN-gamma is mediator of Cxcl10 and Cxcl9 gene expression in experimental autoimmune encephalomyelitis(EAE). It differentially regulates expression of these genes by astrocytes and microglia. Differential glial localization of these chemokines in EAE. PMID: 17902170
  46. The absence of CXCL9 or CXCL10 expression significantly alters the ability of the host to control genital HSV-2 infection through the mobilization of effector cells to sites of infection. PMID: 18178850
  47. These data demonstrate that CXCR3 on CD8(+) T cells is required for T cell recruitment into the brain and the development of murine cerebral malaria. PMID: 18347328
  48. Liver sinusoidal endothelial cells present chemokines (CXCL12 and CXCL9) to circulating lymphocytes. PMID: 18697212
  49. CXCR3 ligands, IP10 and MIG, contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung. PMID: 18716926
  50. CXCL9 promotes protection from coronavirus-induced neurological and liver disease. PMID: 18973912

Show More

Hide All

Subcellular Location
Secreted.
Protein Families
Intercrine alpha (chemokine CxC) family
Database Links

KEGG: mmu:17329

STRING: 10090.ENSMUSP00000108716

UniGene: Mm.766

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*